グライコミックス市場(製品タイプ。製品タイプ:酵素、器具、キット、試薬、アプリケーション。診断、創薬・開発、腫瘍、免疫、その他、エンドユーザー。世界の産業分析、規模、シェア、成長、傾向、予測、2021年~2031年Glycomics Market (Product Type: Enzymes, Instruments, Kits, and Reagents; Application: Diagnostics, Drug Discovery & Development, Oncology, Immunology, and Others; and End-user: Academic Research Institutes, Pharmaceutical and & Biotechnology Companies, and Contract Research Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031 グライコミックス市場 - レポートの範囲 TMRの調査レポート「世界のグリコミックス市場」は、2021年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動... もっと見る
サマリーグライコミックス市場 - レポートの範囲TMRの調査レポート「世界のグリコミックス市場」は、2021年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会についても調査しています。2017年から2019年を過去年、2020年を基準年、2021年から2031年を予測期間とし、2017年から2031年までの世界のグリコミックス市場全体の市場収益を提供します。また、予測期間における世界のグリコミックス市場の複合年間成長率(CAGR)を記載しています。 本レポートは、広範な調査を経て作成されました。一次調査では、アナリストが業界のリーダーやオピニオンメーカーにインタビューを行うなど、大規模な調査活動を行いました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、記事、ジャーナル、関連文書などを参照し、世界のグリコミックス市場を理解しました。 二次調査には、インターネット上の情報源、政府機関の統計データ、ウェブサイト、業界団体も含まれます。アナリストは、世界のグリコミックス市場における様々な現象を研究するために、トップダウンアプローチも採用しています。 本レポートには、調査範囲に含まれる様々なセグメントの成長行動のスナップショットとともに、精緻なエグゼクティブサマリーが含まれています。さらに、世界のグリコミックス市場における競争力学の変化についても光を当てています。これらの指標は、既存の市場関係者だけでなく、世界のグリコミックス市場への参入に関心のある事業者にとっても貴重なツールとなります。次のセクションでは、世界のグリコミックス市場における主要なM&A、技術の進歩、関連する主要研究機関、主要な開発などのUSPに焦点を当てています。 本レポートでは、世界のグリコミックス市場の競争環境について掘り下げています。世界のグリコミックス市場で事業を展開する主要企業が特定され、各企業の特徴的な事業特性についてプロファイルされています。企業概要、財務状況、最近の開発、SWOTなどは、本レポートで紹介されている世界のグリコミックス市場におけるプレイヤーの属性の一部です。 グリコミックス市場レポートにおいて回答された主な質問 世界市場における主要なドライバー、阻害要因、機会は何か? 予測期間中、世界のグリコミックス市場の主要セグメントの収益シェア予測はどうなるのか? 2031年までに収益面で世界のグライコミクス市場をリードしそうなセグメントは何か? プレイヤー間のM&Aはどのように世界のグリコミックス市場の範囲を広げているのか? 世界のグリコミックス市場におけるリーディングカンパニーはどこか? グリコミックス市場 - 研究目的と研究アプローチ 世界のグリコミックス市場に関する包括的なレポートでは、まず市場の概要を説明し、次に本調査の範囲と目的について述べます。続いて、本調査の目的、グリコミックス市場の調査範囲において公認機関が定めた医療コンプライアンスについて詳しく解説しています。続いて、市場導入、市場ダイナミクス、世界のグリコミックス市場の概要が記載されており、世界のグリコミックス市場の成長に影響を与える市場ドライバー、阻害要因、トレンドについてのTMR分析が含まれています。さらに、グリコミックス市場のY-O-Yトレンドを理解するために、精巧な洞察によるY-O-Y分析が提供されています。グリコミックス市場レポートの次のセクションでは、世界市場における技術スナップショット、プロセス概要、著名なソフトウェアツール、主要な産業開発、規制シナリオ、償還シナリオを含むUSPにハイライトを当てます。 読みやすさを考慮して、レポートは章立てでまとめられ、各セクションはさらに小さな節に分けられています。レポート全体では、グラフや表が適切に配置され、網羅的に構成されています。主要セグメントの実績値と予測値を絵で表現することで、読者に視覚的にアピールしています。また、過去と予測期間終了時の主要セグメントの市場シェアの比較も可能です。 本レポートでは、世界のグリコミックス市場を製品タイプ、用途、エンドユーザー、地域の観点から分析しています。各基準における主要セグメントを詳細に調査し、2031年末時点の各セグメントにおける市場シェアを掲載しています。このような貴重な洞察は、市場関係者がグリコミックス市場への投資について十分な情報を得た上でビジネス上の意思決定を行うことを可能にします。 目次1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Glycomics Market 4. Market Overview 4.1. Introduction 4.1.1. Product Type Definition 4.1.2. Industry Evolution / Developments 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Glycomics Market Analysis and Forecast, 2017–2031 4.4.1. Market Revenue Projections (US$ Mn) 5. Key Insights 5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.) 5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact) 5.3. Technological Advancements 6. Global Glycomics Market Analysis and Forecast, by Product Type 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Product Type, 2017–2031 6.3.1. Enzymes 6.3.1.1. Glycosidases 6.3.1.2. Glycosyltransferases 6.3.1.3. Neuraminidases 6.3.1.4. Sialyltransferases 6.3.1.5. Others 6.3.2. Instruments 6.3.2.1. Antibody Arrays 6.3.2.2. HPLC 6.3.2.3. Lectin Arrays 6.3.2.4. MALDI-TOF 6.3.2.5. Other Glycomics Instruments 6.3.3. Kits 6.3.3.1. Glycan Labeling Kits 6.3.3.2. Glycan Purification Kits 6.3.3.3. Glycan Release Kits 6.3.3.4. Others 6.3.4. Reagents 6.3.4.1. Glycoproteins 6.3.4.2. Monosaccharides 6.3.4.3. Oligosaccharides 6.3.4.4. Others 6.4. Market Attractiveness Analysis, by Product Type 7. Global Glycomics Market Analysis and Forecast, by Application 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast, by Application, 2017–2031 7.3.1. Diagnostics 7.3.2. Drug Discovery & Development 7.3.3. Oncology 7.3.4. Immunology 7.3.5. Others 7.4. Market Attractiveness Analysis, by Application 8. Global Glycomics Market Analysis and Forecast End-user 8.1. Introduction & Definition 8.2. Key Findings / Developments 8.3. Market Value Forecast, by End-user, 2017–2031 8.3.1. Academic Research Institute 8.3.2. Pharmaceutical & Biotechnology Companies 8.3.3. Contract Research Organizations 8.4. Market Attractiveness Analysis, by End-user 9. Global Glycomics Market Analysis and Forecast, by Region 9.1. Key Findings 9.2. Market Value Forecast, by Region 9.2.1. North America 9.2.2. Europe 9.2.3. Asia Pacific 9.2.4. Latin America 9.2.5. Middle East & Africa 9.3. Market Attractiveness Analysis, by Country/Region 10. North America Glycomics Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast, by Product Type, 2017–2031 10.2.1. Enzymes 10.2.1.1. Glycosidases 10.2.1.2. Glycosyltransferases 10.2.1.3. Neuraminidases 10.2.1.4. Sialyltransferases 10.2.1.5. Others 10.2.2. Instruments 10.2.2.1. Antibody Arrays 10.2.2.2. HPLC 10.2.2.3. Lectin Arrays 10.2.2.4. MALDI-TOF 10.2.2.5. Other Glycomics Instruments 10.2.3. Kits 10.2.3.1. Glycan Labeling Kits 10.2.3.2. Glycan Purification Kits 10.2.3.3. Glycan Release Kits 10.2.3.4. Others 10.2.4. Reagents 10.2.4.1. Glycoproteins 10.2.4.2. Monosaccharides 10.2.4.3. Oligosaccharides 10.2.4.4. Others 10.3. Market Value Forecast, by Application, 2017–2031 10.3.1. Diagnostics 10.3.2. Drug Discovery & Development 10.3.3. Oncology 10.3.4. Immunology 10.3.5. Others 10.4. Market Value Forecast, by End-user, 2017–2031 10.4.1. Academic Research Institute 10.4.2. Pharmaceutical & Biotechnology Companies 10.4.3. Contract Research Organizations 10.5. Market Value Forecast, by Country, 2017–2031 10.5.1. U.S. 10.5.2. Canada 10.6. Market Attractiveness Analysis 10.6.1. By Product Type 10.6.2. By Application 10.6.3. By End-user 10.6.4. By Country 11. Europe Glycomics Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Product Type, 2017–2031 11.2.1. Enzymes 11.2.1.1. Glycosidases 11.2.1.2. Glycosyltransferases 11.2.1.3. Neuraminidases 11.2.1.4. Sialyltransferases 11.2.1.5. Others 11.2.2. Instruments 11.2.2.1. Antibody Arrays 11.2.2.2. HPLC 11.2.2.3. Lectin Arrays 11.2.2.4. MALDI-TOF 11.2.2.5. Other Glycomics Instruments 11.2.3. Kits 11.2.3.1. Glycan Labeling Kits 11.2.3.2. Glycan Purification Kits 11.2.3.3. Glycan Release Kits 11.2.3.4. Others 11.2.4. Reagents 11.2.4.1. Glycoproteins 11.2.4.2. Monosaccharides 11.2.4.3. Oligosaccharides 11.2.4.4. Others 11.3. Market Value Forecast Application, 2017–2031 11.3.1. Diagnostics 11.3.2. Drug Discovery & Development 11.3.3. Oncology 11.3.4. Immunology 11.3.5. Others 11.4. Market Value Forecast, by End-user, 2017–2031 11.4.1. Academic Research Institute 11.4.2. Pharmaceutical & Biotechnology Companies 11.4.3. Contract Research Organizations 11.5. Market Value Forecast, by Country/Sub-region, 2017–2031 11.5.1. U.K. 11.5.2. Germany 11.5.3. France 11.5.4. Spain 11.5.5. Italy 11.5.6. Rest of Europe 11.6. Market Attractiveness Analysis 11.6.1. By Product Type 11.6.2. By Application 11.6.3. By End-user 11.6.4. By Country/Sub-region 12. Asia Pacific Glycomics Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Product Type, 2017–2031 12.2.1. Enzymes 12.2.1.1. Glycosidases 12.2.1.2. Glycosyltransferases 12.2.1.3. Neuraminidases 12.2.1.4. Sialyltransferases 12.2.1.5. Others 12.2.2. Instruments 12.2.2.1. Antibody Arrays 12.2.2.2. HPLC 12.2.2.3. Lectin Arrays 12.2.2.4. MALDI-TOF 12.2.2.5. Other Glycomics Instruments 12.2.3. Kits 12.2.3.1. Glycan Labeling Kits 12.2.3.2. Glycan Purification Kits 12.2.3.3. Glycan Release Kits 12.2.3.4. Others 12.2.4. Reagents 12.2.4.1. Glycoproteins 12.2.4.2. Monosaccharides 12.2.4.3. Oligosaccharides 12.2.4.4. Others 12.3. Market Value Forecast, by Application, 2017–2031 12.3.1. Diagnostics 12.3.2. Drug Discovery & Development 12.3.3. Oncology 12.3.4. Immunology 12.3.5. Others 12.4. Market Value Forecast, by End-user, 2017–2031 12.4.1. Academic Research Institute 12.4.2. Pharmaceutical & Biotechnology Companies 12.4.3. Contract Research Organizations 12.5. Market Value Forecast, by Country/Sub-region, 2017–2031 12.5.1. China 12.5.2. India 12.5.3. Japan 12.5.4. Australia & New Zealand 12.5.5. Rest of Asia Pacific 12.6. Market Attractiveness Analysis 12.6.1. By Product Type 12.6.2. By Application 12.6.3. By End-user 12.6.4. By Country/Sub-region 13. Latin America Glycomics Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Product Type, 2017–2031 13.2.1. Enzymes 13.2.1.1. Glycosidases 13.2.1.2. Glycosyltransferases 13.2.1.3. Neuraminidases 13.2.1.4. Sialyltransferases 13.2.1.5. Others 13.2.2. Instruments 13.2.2.1. Antibody Arrays 13.2.2.2. HPLC 13.2.2.3. Lectin Arrays 13.2.2.4. MALDI-TOF 13.2.2.5. Other Glycomics Instruments 13.2.3. Kits 13.2.3.1. Glycan Labeling Kits 13.2.3.2. Glycan Purification Kits 13.2.3.3. Glycan Release Kits 13.2.3.4. Others 13.2.4. Reagents 13.2.4.1. Glycoproteins 13.2.4.2. Monosaccharides 13.2.4.3. Oligosaccharides 13.2.4.4. Others 13.3. Market Value Forecast, by Application, 2017–2031 13.3.1. Diagnostics 13.3.2. Drug Discovery & Development 13.3.3. Oncology 13.3.4. Immunology 13.3.5. Others 13.4. Market Value Forecast, by End-user, 2017–2031 13.4.1. Academic Research Institute 13.4.2. Pharmaceutical & Biotechnology Companies 13.4.3. Contract Research Organizations 13.5. Market Value Forecast, by Country/Sub-region, 2017–2031 13.5.1. Brazil 13.5.2. Mexico 13.5.3. Rest of Latin America 13.6. Market Attractiveness Analysis 13.6.1. By Product Type 13.6.2. By Application 13.6.3. By End-user 13.6.4. By Country/Sub-region 14. Middle East & Africa Glycomics Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.2. Market Value Forecast, by Product Type, 2017–2031 14.2.1. Enzymes 14.2.1.1. Glycosidases 14.2.1.2. Glycosyltransferases 14.2.1.3. Neuraminidases 14.2.1.4. Sialyltransferases 14.2.1.5. Others 14.2.2. Instruments 14.2.2.1. Antibody Arrays 14.2.2.2. HPLC 14.2.2.3. Lectin Arrays 14.2.2.4. MALDI-TOF 14.2.2.5. Other Glycomics Instruments 14.2.3. Kits 14.2.3.1. Glycan Labeling Kits 14.2.3.2. Glycan Purification Kits 14.2.3.3. Glycan Release Kits 14.2.3.4. Others 14.2.4. Reagents 14.2.4.1. Glycoproteins 14.2.4.2. Monosaccharides 14.2.4.3. Oligosaccharides 14.2.4.4. Others 14.3. Market Value Forecast, by Application, 2017–2031 14.3.1. Diagnostics 14.3.2. Drug Discovery & Development 14.3.3. Oncology 14.3.4. Immunology 14.3.5. Others 14.4. Market Value Forecast, by End-user, 2017–2031 14.4.1. Academic Research Institute 14.4.2. Pharmaceutical & Biotechnology Companies 14.4.3. Contract Research Organizations 14.5. Market Value Forecast, by Country/Sub-region, 2017–2031 14.5.1. GCC Countries 14.5.2. South Africa 14.5.3. Rest of Middle East & Africa 14.6. Market Attractiveness Analysis 14.6.1. By Product Type 14.6.2. By Application 14.6.3. By End-user 14.6.4. By Country/Sub-region 15. Competition Landscape 15.1. Market Player - Competition Matrix 15.2. Market Share Analysis, by Company, 2020 15.3. Competitive Business Strategies 15.4. Company Profiles 15.4.1. Agilent Technologies, Inc. 15.4.1.1. Company Description 15.4.1.2. Business Overview 15.4.1.3. Financial Overview 15.4.1.4. SWOT Analysis 15.4.2. Asparia Glycomics 15.4.2.1. Company Description 15.4.2.2. SWOT Analysis 15.4.3. Bruker Corporation 15.4.3.1. Company Description 15.4.3.2. Business Overview 15.4.3.3. Financial Overview 15.4.3.4. SWOT Analysis 15.4.4. Canadian Glycomics Network (GLYCONET) 15.4.4.1. Company Description 15.4.4.2. Business Overview 15.4.4.3. SWOT Analysis 15.4.5. Glyco Expression Technologies, Inc. 15.4.5.1. Company Description 15.4.5.2. SWOT Analysis 15.4.6. Glycodiag 15.4.6.1. Company Description 15.4.6.2. Business Overview 15.4.6.3. SWOT Analysis 15.4.7. Merck KGaA 15.4.7.1. Company Description 15.4.7.2. Business Overview 15.4.7.3. Financial Overview 15.4.7.4. SWOT Analysis 15.4.8. New England Biolabs 15.4.8.1. Company Description 15.4.8.2. Business Overview 15.4.8.3. SWOT Analysis 15.4.9. RayBiotech, Inc. 15.4.9.1. Company Description 15.4.9.2. SWOT Analysis 15.4.10. Shimadzu Corporation 15.4.10.1. Company Description 15.4.10.2. Business Overview 15.4.10.3. Financial Overview 15.4.10.4. SWOT Analysis 15.4.11. Thermo Fisher Scientific, Inc. 15.4.11.1. Company Description 15.4.11.2. Business Overview 15.4.11.3. Financial Overview 15.4.11.4. SWOT Analysis 15.4.12. Vector Laboratories 15.4.12.1. Company Description 15.4.12.2. Business Overview 15.4.12.3. SWOT Analysis 15.4.13. Glyde Bio, Inc. 15.4.13.1. Company Description 15.4.13.2. SWOT Analysis
SummaryGlycomics Market – Scope of Report Table of Contents1. Preface1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Glycomics Market 4. Market Overview 4.1. Introduction 4.1.1. Product Type Definition 4.1.2. Industry Evolution / Developments 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Glycomics Market Analysis and Forecast, 2017–2031 4.4.1. Market Revenue Projections (US$ Mn) 5. Key Insights 5.1. Key Industry Events (mergers, acquisitions, partnerships, etc.) 5.2. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact) 5.3. Technological Advancements 6. Global Glycomics Market Analysis and Forecast, by Product Type 6.1. Introduction & Definition 6.2. Key Findings / Developments 6.3. Market Value Forecast, by Product Type, 2017–2031 6.3.1. Enzymes 6.3.1.1. Glycosidases 6.3.1.2. Glycosyltransferases 6.3.1.3. Neuraminidases 6.3.1.4. Sialyltransferases 6.3.1.5. Others 6.3.2. Instruments 6.3.2.1. Antibody Arrays 6.3.2.2. HPLC 6.3.2.3. Lectin Arrays 6.3.2.4. MALDI-TOF 6.3.2.5. Other Glycomics Instruments 6.3.3. Kits 6.3.3.1. Glycan Labeling Kits 6.3.3.2. Glycan Purification Kits 6.3.3.3. Glycan Release Kits 6.3.3.4. Others 6.3.4. Reagents 6.3.4.1. Glycoproteins 6.3.4.2. Monosaccharides 6.3.4.3. Oligosaccharides 6.3.4.4. Others 6.4. Market Attractiveness Analysis, by Product Type 7. Global Glycomics Market Analysis and Forecast, by Application 7.1. Introduction & Definition 7.2. Key Findings / Developments 7.3. Market Value Forecast, by Application, 2017–2031 7.3.1. Diagnostics 7.3.2. Drug Discovery & Development 7.3.3. Oncology 7.3.4. Immunology 7.3.5. Others 7.4. Market Attractiveness Analysis, by Application 8. Global Glycomics Market Analysis and Forecast End-user 8.1. Introduction & Definition 8.2. Key Findings / Developments 8.3. Market Value Forecast, by End-user, 2017–2031 8.3.1. Academic Research Institute 8.3.2. Pharmaceutical & Biotechnology Companies 8.3.3. Contract Research Organizations 8.4. Market Attractiveness Analysis, by End-user 9. Global Glycomics Market Analysis and Forecast, by Region 9.1. Key Findings 9.2. Market Value Forecast, by Region 9.2.1. North America 9.2.2. Europe 9.2.3. Asia Pacific 9.2.4. Latin America 9.2.5. Middle East & Africa 9.3. Market Attractiveness Analysis, by Country/Region 10. North America Glycomics Market Analysis and Forecast 10.1. Introduction 10.1.1. Key Findings 10.2. Market Value Forecast, by Product Type, 2017–2031 10.2.1. Enzymes 10.2.1.1. Glycosidases 10.2.1.2. Glycosyltransferases 10.2.1.3. Neuraminidases 10.2.1.4. Sialyltransferases 10.2.1.5. Others 10.2.2. Instruments 10.2.2.1. Antibody Arrays 10.2.2.2. HPLC 10.2.2.3. Lectin Arrays 10.2.2.4. MALDI-TOF 10.2.2.5. Other Glycomics Instruments 10.2.3. Kits 10.2.3.1. Glycan Labeling Kits 10.2.3.2. Glycan Purification Kits 10.2.3.3. Glycan Release Kits 10.2.3.4. Others 10.2.4. Reagents 10.2.4.1. Glycoproteins 10.2.4.2. Monosaccharides 10.2.4.3. Oligosaccharides 10.2.4.4. Others 10.3. Market Value Forecast, by Application, 2017–2031 10.3.1. Diagnostics 10.3.2. Drug Discovery & Development 10.3.3. Oncology 10.3.4. Immunology 10.3.5. Others 10.4. Market Value Forecast, by End-user, 2017–2031 10.4.1. Academic Research Institute 10.4.2. Pharmaceutical & Biotechnology Companies 10.4.3. Contract Research Organizations 10.5. Market Value Forecast, by Country, 2017–2031 10.5.1. U.S. 10.5.2. Canada 10.6. Market Attractiveness Analysis 10.6.1. By Product Type 10.6.2. By Application 10.6.3. By End-user 10.6.4. By Country 11. Europe Glycomics Market Analysis and Forecast 11.1. Introduction 11.1.1. Key Findings 11.2. Market Value Forecast, by Product Type, 2017–2031 11.2.1. Enzymes 11.2.1.1. Glycosidases 11.2.1.2. Glycosyltransferases 11.2.1.3. Neuraminidases 11.2.1.4. Sialyltransferases 11.2.1.5. Others 11.2.2. Instruments 11.2.2.1. Antibody Arrays 11.2.2.2. HPLC 11.2.2.3. Lectin Arrays 11.2.2.4. MALDI-TOF 11.2.2.5. Other Glycomics Instruments 11.2.3. Kits 11.2.3.1. Glycan Labeling Kits 11.2.3.2. Glycan Purification Kits 11.2.3.3. Glycan Release Kits 11.2.3.4. Others 11.2.4. Reagents 11.2.4.1. Glycoproteins 11.2.4.2. Monosaccharides 11.2.4.3. Oligosaccharides 11.2.4.4. Others 11.3. Market Value Forecast Application, 2017–2031 11.3.1. Diagnostics 11.3.2. Drug Discovery & Development 11.3.3. Oncology 11.3.4. Immunology 11.3.5. Others 11.4. Market Value Forecast, by End-user, 2017–2031 11.4.1. Academic Research Institute 11.4.2. Pharmaceutical & Biotechnology Companies 11.4.3. Contract Research Organizations 11.5. Market Value Forecast, by Country/Sub-region, 2017–2031 11.5.1. U.K. 11.5.2. Germany 11.5.3. France 11.5.4. Spain 11.5.5. Italy 11.5.6. Rest of Europe 11.6. Market Attractiveness Analysis 11.6.1. By Product Type 11.6.2. By Application 11.6.3. By End-user 11.6.4. By Country/Sub-region 12. Asia Pacific Glycomics Market Analysis and Forecast 12.1. Introduction 12.1.1. Key Findings 12.2. Market Value Forecast, by Product Type, 2017–2031 12.2.1. Enzymes 12.2.1.1. Glycosidases 12.2.1.2. Glycosyltransferases 12.2.1.3. Neuraminidases 12.2.1.4. Sialyltransferases 12.2.1.5. Others 12.2.2. Instruments 12.2.2.1. Antibody Arrays 12.2.2.2. HPLC 12.2.2.3. Lectin Arrays 12.2.2.4. MALDI-TOF 12.2.2.5. Other Glycomics Instruments 12.2.3. Kits 12.2.3.1. Glycan Labeling Kits 12.2.3.2. Glycan Purification Kits 12.2.3.3. Glycan Release Kits 12.2.3.4. Others 12.2.4. Reagents 12.2.4.1. Glycoproteins 12.2.4.2. Monosaccharides 12.2.4.3. Oligosaccharides 12.2.4.4. Others 12.3. Market Value Forecast, by Application, 2017–2031 12.3.1. Diagnostics 12.3.2. Drug Discovery & Development 12.3.3. Oncology 12.3.4. Immunology 12.3.5. Others 12.4. Market Value Forecast, by End-user, 2017–2031 12.4.1. Academic Research Institute 12.4.2. Pharmaceutical & Biotechnology Companies 12.4.3. Contract Research Organizations 12.5. Market Value Forecast, by Country/Sub-region, 2017–2031 12.5.1. China 12.5.2. India 12.5.3. Japan 12.5.4. Australia & New Zealand 12.5.5. Rest of Asia Pacific 12.6. Market Attractiveness Analysis 12.6.1. By Product Type 12.6.2. By Application 12.6.3. By End-user 12.6.4. By Country/Sub-region 13. Latin America Glycomics Market Analysis and Forecast 13.1. Introduction 13.1.1. Key Findings 13.2. Market Value Forecast, by Product Type, 2017–2031 13.2.1. Enzymes 13.2.1.1. Glycosidases 13.2.1.2. Glycosyltransferases 13.2.1.3. Neuraminidases 13.2.1.4. Sialyltransferases 13.2.1.5. Others 13.2.2. Instruments 13.2.2.1. Antibody Arrays 13.2.2.2. HPLC 13.2.2.3. Lectin Arrays 13.2.2.4. MALDI-TOF 13.2.2.5. Other Glycomics Instruments 13.2.3. Kits 13.2.3.1. Glycan Labeling Kits 13.2.3.2. Glycan Purification Kits 13.2.3.3. Glycan Release Kits 13.2.3.4. Others 13.2.4. Reagents 13.2.4.1. Glycoproteins 13.2.4.2. Monosaccharides 13.2.4.3. Oligosaccharides 13.2.4.4. Others 13.3. Market Value Forecast, by Application, 2017–2031 13.3.1. Diagnostics 13.3.2. Drug Discovery & Development 13.3.3. Oncology 13.3.4. Immunology 13.3.5. Others 13.4. Market Value Forecast, by End-user, 2017–2031 13.4.1. Academic Research Institute 13.4.2. Pharmaceutical & Biotechnology Companies 13.4.3. Contract Research Organizations 13.5. Market Value Forecast, by Country/Sub-region, 2017–2031 13.5.1. Brazil 13.5.2. Mexico 13.5.3. Rest of Latin America 13.6. Market Attractiveness Analysis 13.6.1. By Product Type 13.6.2. By Application 13.6.3. By End-user 13.6.4. By Country/Sub-region 14. Middle East & Africa Glycomics Market Analysis and Forecast 14.1. Introduction 14.1.1. Key Findings 14.2. Market Value Forecast, by Product Type, 2017–2031 14.2.1. Enzymes 14.2.1.1. Glycosidases 14.2.1.2. Glycosyltransferases 14.2.1.3. Neuraminidases 14.2.1.4. Sialyltransferases 14.2.1.5. Others 14.2.2. Instruments 14.2.2.1. Antibody Arrays 14.2.2.2. HPLC 14.2.2.3. Lectin Arrays 14.2.2.4. MALDI-TOF 14.2.2.5. Other Glycomics Instruments 14.2.3. Kits 14.2.3.1. Glycan Labeling Kits 14.2.3.2. Glycan Purification Kits 14.2.3.3. Glycan Release Kits 14.2.3.4. Others 14.2.4. Reagents 14.2.4.1. Glycoproteins 14.2.4.2. Monosaccharides 14.2.4.3. Oligosaccharides 14.2.4.4. Others 14.3. Market Value Forecast, by Application, 2017–2031 14.3.1. Diagnostics 14.3.2. Drug Discovery & Development 14.3.3. Oncology 14.3.4. Immunology 14.3.5. Others 14.4. Market Value Forecast, by End-user, 2017–2031 14.4.1. Academic Research Institute 14.4.2. Pharmaceutical & Biotechnology Companies 14.4.3. Contract Research Organizations 14.5. Market Value Forecast, by Country/Sub-region, 2017–2031 14.5.1. GCC Countries 14.5.2. South Africa 14.5.3. Rest of Middle East & Africa 14.6. Market Attractiveness Analysis 14.6.1. By Product Type 14.6.2. By Application 14.6.3. By End-user 14.6.4. By Country/Sub-region 15. Competition Landscape 15.1. Market Player - Competition Matrix 15.2. Market Share Analysis, by Company, 2020 15.3. Competitive Business Strategies 15.4. Company Profiles 15.4.1. Agilent Technologies, Inc. 15.4.1.1. Company Description 15.4.1.2. Business Overview 15.4.1.3. Financial Overview 15.4.1.4. SWOT Analysis 15.4.2. Asparia Glycomics 15.4.2.1. Company Description 15.4.2.2. SWOT Analysis 15.4.3. Bruker Corporation 15.4.3.1. Company Description 15.4.3.2. Business Overview 15.4.3.3. Financial Overview 15.4.3.4. SWOT Analysis 15.4.4. Canadian Glycomics Network (GLYCONET) 15.4.4.1. Company Description 15.4.4.2. Business Overview 15.4.4.3. SWOT Analysis 15.4.5. Glyco Expression Technologies, Inc. 15.4.5.1. Company Description 15.4.5.2. SWOT Analysis 15.4.6. Glycodiag 15.4.6.1. Company Description 15.4.6.2. Business Overview 15.4.6.3. SWOT Analysis 15.4.7. Merck KGaA 15.4.7.1. Company Description 15.4.7.2. Business Overview 15.4.7.3. Financial Overview 15.4.7.4. SWOT Analysis 15.4.8. New England Biolabs 15.4.8.1. Company Description 15.4.8.2. Business Overview 15.4.8.3. SWOT Analysis 15.4.9. RayBiotech, Inc. 15.4.9.1. Company Description 15.4.9.2. SWOT Analysis 15.4.10. Shimadzu Corporation 15.4.10.1. Company Description 15.4.10.2. Business Overview 15.4.10.3. Financial Overview 15.4.10.4. SWOT Analysis 15.4.11. Thermo Fisher Scientific, Inc. 15.4.11.1. Company Description 15.4.11.2. Business Overview 15.4.11.3. Financial Overview 15.4.11.4. SWOT Analysis 15.4.12. Vector Laboratories 15.4.12.1. Company Description 15.4.12.2. Business Overview 15.4.12.3. SWOT Analysis 15.4.13. Glyde Bio, Inc. 15.4.13.1. Company Description 15.4.13.2. SWOT Analysis
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(バイオ薬物)の最新刊レポート
Transparency Market Research 社の最新刊レポート
本レポートと同じKEY WORD(oncology)の最新刊レポート
よくあるご質問Transparency Market Research社はどのような調査会社ですか?トレンスペアレンシーマーケットリサーチ(Transparency Market Research /TMR)は市場参入やホワイトスペースの特定、新商品や新サービスの立ち上げ、戦略的M&Aなどの実現のた... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/08 10:26 154.13 円 166.76 円 202.76 円 |